T&R Biofab Statistics

Total Valuation

T&R Biofab has a market cap or net worth of KRW 146.04 billion. The enterprise value is 167.74 billion.

Market Cap	146.04B
Enterprise Value	167.74B

Important Dates

The next estimated earnings date is Monday, June 1, 2026.

Earnings Date	Jun 1, 2026
Ex-Dividend Date	n/a

Share Statistics

T&R Biofab has 47.57 million shares outstanding. The number of shares has increased by 23.66% in one year.

Current Share Class	47.57M
Shares Outstanding	47.57M
Shares Change (YoY)	+23.66%
Shares Change (QoQ)	+193.51%
Owned by Insiders (%)	15.20%
Owned by Institutions (%)	2.79%
Float	40.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.42
PB Ratio	6.33
P/TBV Ratio	6.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.80
EV / Sales	6.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.45

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 1.28.

Current Ratio	1.09
Quick Ratio	0.79
Debt / Equity	1.28
Debt / EBITDA	n/a
Debt / FCF	-3.08
Interest Coverage	-1.42

Financial Efficiency

Return on equity (ROE) is -140.81% and return on invested capital (ROIC) is -8.65%.

Return on Equity (ROE)	-140.81%
Return on Assets (ROA)	-5.67%
Return on Invested Capital (ROIC)	-8.65%
Return on Capital Employed (ROCE)	-11.43%
Weighted Average Cost of Capital (WACC)	9.04%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.28
Inventory Turnover	4.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.45% in the last 52 weeks. The beta is 0.61, so T&R Biofab's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-27.45%
50-Day Moving Average	3,094.20
200-Day Moving Average	2,761.59
Relative Strength Index (RSI)	45.99
Average Volume (20 Days)	378,213

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, T&R Biofab had revenue of KRW 26.97 billion and -34.94 billion in losses. Loss per share was -1,093.00.

Revenue	26.97B
Gross Profit	6.83B
Operating Income	-8.67B
Pretax Income	-34.94B
Net Income	-34.94B
EBITDA	-3.63B
EBIT	-8.67B
Loss Per Share	-1,093.00

Full Income Statement

Balance Sheet

The company has 7.86 billion in cash and 29.56 billion in debt, giving a net cash position of -21.70 billion or -456.22 per share.

Cash & Cash Equivalents	7.86B
Total Debt	29.56B
Net Cash	-21.70B
Net Cash Per Share	-456.22
Equity (Book Value)	23.08B
Book Value Per Share	364.91
Working Capital	1.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.47 billion and capital expenditures -2.15 billion, giving a free cash flow of -9.61 billion.

Operating Cash Flow	-7.47B
Capital Expenditures	-2.15B
Depreciation & Amortization	5.03B
Net Borrowing	-25.31B
Free Cash Flow	-9.61B
FCF Per Share	-202.06

Full Cash Flow Statement

Margins

Gross margin is 25.32%, with operating and profit margins of -32.14% and -129.58%.

Gross Margin	25.32%
Operating Margin	-32.14%
Pretax Margin	-129.58%
Profit Margin	-129.58%
EBITDA Margin	-13.48%
EBIT Margin	-32.14%
FCF Margin	n/a

Dividends & Yields

T&R Biofab does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.66%
Shareholder Yield	-23.66%
Earnings Yield	-23.93%
FCF Yield	-6.58%

Stock Splits

The last stock split was on October 29, 2025. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 29, 2025
Split Type	Forward
Split Ratio	1.2

Scores

T&R Biofab has an Altman Z-Score of -1.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.87
Piotroski F-Score	3